Table 5 Sociodemographic and clinical characteristics: Part B-daily diary study
Characteristic | Total N = 76 |
|---|---|
Age | |
Mean (SD) | 41.9 (13.2) |
Median [Range] | 40.5 [19–70] |
Gender, n (%) | |
Female | 50 (65.8) |
Racial background, n (%)a | |
Asian | 2 (2.6) |
Black or African American | 11 (14.5) |
White | 63 (82.9) |
Other (not specified) | 1 (1.3) |
Missing | 1 (1.3) |
Ethnicity, n (%) | |
Hispanic or Latino | 4 (5.3) |
Not Hispanic or Latino | 72 (94.7) |
Employment status, n (%)a | |
Employed, full-time | 42 (55.3) |
Employed, part-time | 10 (13.2) |
Homemaker/stay-at-home parent | 5 (6.6) |
Student | 5 (6.6) |
Unemployed | 4 (5.3) |
Retired | 3 (3.9) |
Disabled | 9 (11.8) |
Otherb | 2 (2.6) |
Highest level of education, n (%) | |
Secondary/high school | 4 (5.3) |
Some college | 12 (15.8) |
College degree | 46 (60.5) |
Postgraduate degree | 14 (18.4) |
Time since diagnosis of Crohn’s disease, years | |
Mean (SD) | 11.8 (11.8) |
Median [Range] | 7.5 [0–48] |
Current CD treatment, n (%)a | |
I am not currently taking any treatment for my Crohn’s disease | 3 (3.9) |
Biologic (adalimumab, vedolizumab, ustekinumab, infliximab, golimumab, certolizumab, etc.) | 56 (73.7) |
Immunomodulators (azathioprine, mercaptopurine, methotrexate, etc.) | 17 (22.4) |
Corticosteroids (prednisone, budesonide, hydrocortisone, etc.) | 14 (18.4) |
Otherc | 11 (14.5) |
Missing | 1 (1.3) |
Comorbid health conditions, n (%)a | |
I do not have any other health conditions besides Crohn’s disease | 29 (38.2) |
Allergic rhinitis | 7 (9.2) |
Ankylosing spondylitis | 1 (1.3) |
Anxietyd | 5 (6.6) |
Asthma | 8 (10.5) |
Celiac disease | 3 (3.9) |
COPD or emphysema | 1 (1.3) |
Depression | 19 (25.0) |
Diabetes (Type 2) | 2 (2.6) |
Hypertension | 12 (15.8) |
Multiple sclerosis | 1 (1.3) |
Psoriasis | 5 (6.6) |
Osteoarthritis | 1 (1.3) |
Rheumatoid arthritis | 6 (7.9) |
Other autoimmune condition(s)e | 4 (5.3) |
Other mental health condition(s)f | 1 (1.3) |
Other health condition(s)g | 11 (14.5) |
Missing | 2 (2.6%) |